Patents Represented by Attorney Potter Anderson & Corroon LLP
  • Patent number: 6613331
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: September 2, 2003
    Assignees: Max-Planck-Gessellschaft zur förderung der Wissenschaften e.V., Deutsches Krebsforschun zentrum Stiftung des öffentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard